Globe Newswire
8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor... (continue reading...)TULSA, Okla., April 23, 2024 (GLOBE NEWSWIRE) -- Ladybug Resource Group, Inc. (OTC PINK: LBRG), operating as Ladybug NutraTech, is delighted to announce the expansion of its logistical capabilities with the opening of a second warehouse by Fitness Fuel Depot Ltd. (herein referred to as “FFD”) This new facility, located in the greater Toronto area, is specifically designed to accommodate the growing inventory requirements of Ladybug’s e-commerce platforms. This... (continue reading...)
COLOGNE, Germany and ZURICH, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- Trawick International GmbH, a subsidiary of Trawick Holdings, LLC, an industry-leading international insurance company, has announced a strategic relationship with insurer Zurich Benelux.
This collaborative effort, formalized on April 1st, 2024, will support Trawick International's offerings in the student insurance sector, marking a significant enhancement of its most long-standing... (continue reading...)
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. (Nasdaq: STAF) (“Staffing 360” or the “Company”), a company executing a buy-integrate-build strategy through the acquisition of staffing organizations in the United States, today reported that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirements of Nasdaq... (continue reading...)
8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor... (continue reading...)More Globe Newswire
View Older Stories-
Shifting Regulations and Emerging Threats Cause Nearly a Third of CISOs to Consider Leaving Their Roles
-
TMC & SGS Produce World-First Nickel Sulfate from Deep-Seafloor Polymetallic Nodules
-
Old National Bancorp Reports First Quarter 2024 Results
-
Xometry to Announce First Quarter 2024 Financial Results on May 9, 2024
-
Baker Hughes Awarded Significant Gas Technology Scope for Phase 3 of Saudi Arabia’s Master Gas System
-
Preferred Bank Reports Quarterly Results
-
TMC & SGS Produce World-First Nickel Sulfate from Deep-Seafloor Polymetallic Nodules
-
Altus Group Announces Winners of the 2024 ARGUS University Challenge
-
Parex Resources Announces Timing of Q1 2024 Results, Annual General Meeting, and Foothills Investor Presentation
-
Solid Power, Inc. Announces Timing of First Quarter 2024 Earnings Release and Conference Call
-
WEST MINING ANNOUNCES PRIVATE PLACEMENT
-
Dominion Lending Centres Inc. Announces First Quarter 2024 Earnings Release Date
-
Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market
-
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
-
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infecti
-
Big 5 Sporting Goods Corporation to Report Fiscal 2024 First Quarter Results on April 30, 2024
-
Crowdbotics Enters Collaboration with Microsoft to Accelerate App Development with CodeOps
-
Monarch Private Capital and Elawan Energy Announce Substantial Completion of Two Renewable Energy Projects
-
Vital Battery Metals Announces 2024 Exploration & Drilling Program on its Sting Copper Project
-
LifeMD to Participate in Upcoming Investor and Industry Conferences During May
-
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
-
SpecialtyVETPATH Taps Proscia For A Full Transformation Of Its Pathology Operations
-
Code42 to Showcase Insider Threat and Source Code Protection at RSA Conference
-
OncoC4 Announces FDA Clearance of IND Application for Novel SIGLEC 10 Immune Checkpoint Inhibitor ONC-841 for Solid Tumors
-
RTI Earns 2024 Great Place To Work Certification™ in the U.S. and Spain for the Sixth Consecutive Year
-
INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
-
Panelite releases product lines for Peterbilt 589
-
Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
-
Launching Reach 2.0: Next-Gen Event Marketing Platform for Webinars and Field Marketing Events
-
Aemetis to Present to Institutional Investors at UBS, JP Morgan and Stifel Conferences to Review Recent Federal Approval of $200 Million of EB-5 Funding for SAF, Biogas, and CCS Projects
-
Coda Octopus Group Reports Sizable Sale of Echoscope PIPE® Sonars to Major Offshore Service Provider.
-
Energy and Water Development Corp. (EAWD) Appoints Bevilacqua PLLC as SEC and Capital Markets Counsel
-
Luckin Coffee to Announce First Quarter 2024 Financial Results on April 30, 2024
-
Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
-
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
-
INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
-
Clinical ink announces GlucoseReady™
-
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
-
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
-
Monarch Private Capital and Elawan Energy Announce Substantial Completion of Two Renewable Energy Projects
-
G2 Spring 2024 Report: Huntress Claims Dominance in Endpoint and Managed Detection, Named Industry Leader
-
PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic
-
Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT
-
Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
-
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
-
CEX.IO’s Mark Taylor, Global Head of Financial Crime to Join Panel Organized by C5
-
Arteris to Announce Financial Results for the First Quarter 2024 on Thursday, May 2, 2024
-
Equipment Leasing and Finance Association’s Survey of Economic Activity: Monthly Leasing and Finance Index
-
InnovAge to Announce Fiscal Third Quarter 2024 Financial Results and Host Conference Call Tuesday, May 7, 2024
-
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immunology Expert, as Executive Vice President and Head of Research and Development, and Strengthens Sci